AIDS Education pp 173-177 | Cite as

Prevention of HIV-Infection in Prisons

A European Network
  • Caren Weilandt
  • Michel Rotily


There is a growing body of literature in the field of intravenous drug use and HIV/AIDS, but nevertheless it is still a matter of debate whether the prisons accelerate or decrease the spread of HIV and AIDS. Prison populations are rising, and in many countries between a quarter and a half of prisoners have injected drugs before imprisonment (1) and many of those continue drug use while inside prison (2). Although several studies in the European region confirmed significant correlation between a history of imprisonment and positive serostatus among i.v. drug users (IVDU)(3, 4), it is still a matter of debate whether the risk of HIV transmission for IVDU is higher inside or outside prison. There is concern, however, that prisons are settings where IVDU still put themselves at high risk for HIV-in-fection by being forced to practise risky injecting behaviour. In prisons, injection equipment is in very short supply and commonly used by different drug users.


Risk Behaviour Drug User Intravenous Drug Inject Drug User Epidemiological Surveillance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Turnbull, P.J., Dolan K.A., Stimson, G.V. (1991): Prison, HIV and AIDS: risks and experiences in custodial care. Horsham: AVERTGoogle Scholar
  2. 2.
    Power, K.G., Markova, I., Rowlands, A., McKee, A.J., Anslow, P.J., Kifedder, C. (1992): Intravenous drug use and HIV transmission among inmates in Scottish prisons. Br J Addiction, 87:35–45CrossRefGoogle Scholar
  3. 3.
    Richardson, C, Ancelle-Park, R., Papaevangelou, G. for the European Community Study Group on HIV in Injecting Drug Users (1993): Factors associated with HIV seropositivity in European injecting drug users. AIDS, 7, S. 1485–1491PubMedCrossRefGoogle Scholar
  4. 4.
    Rotily, M., Galinier-Pujol, A., Obadia, Y, Moutti, J.P., Toubiana, P., Vernay-Vaisse, C., Gastaut, G.A. (1994): HIV Testing, HIV infection and associated risk factors among inmates in Southeastern French prisons, AIDS, 8:1341–1344PubMedCrossRefGoogle Scholar
  5. 5.
    Pickering, H. & Stimson, G.V. (1993): Syringe sharing in prison. Lancet, 342, S. 621–622PubMedCrossRefGoogle Scholar
  6. 6.
    Bath, G.E., Davies, A.G., Dominy, N.J. et al. (1993): Imprisonment and HIV prevalence (letter). Lancet, 342, S.1368PubMedCrossRefGoogle Scholar
  7. 7.
    Bird, A.G., Gore, S.M., Jolifte, D.W., Burns, S.M. (1992): Anonymous HIV surveillance in Saughton Prison, Edinburgh. AIDS, 6, 725–733PubMedCrossRefGoogle Scholar
  8. 8.
    Centers for Disease Control and Prevention (1990): Update: reducing HIV transmission in intravenous drug users not in drug treatment in the United States. MMWR, 39: 529, 535–538Google Scholar
  9. 9.
    Alcabes, P., Vlahov, D., Anthony, J.C. (1992): Correlates of HIV infection in intravenous drug users: are treatment program samples misleading? Br J Addiction, 87: 47–54CrossRefGoogle Scholar
  10. 10.
    Covell, R.G., Frischer, M., Taylor, A., et al. (1993): Prison experience of injecting drug users in Glasgow. Drug Alcohol Depend, 32: 9–14PubMedCrossRefGoogle Scholar
  11. 11.
    Carvell, A.L.M., Hart, G.J. (1990): Risk behaviours for HIV infection among drug users in prison. BMI, 300: 1383–1385.CrossRefGoogle Scholar
  12. 12.
    Taylor, A., Goldberg, D., Frischer, M., Emslie, J., Green, S., McKeganey, N (1993): Transmission of HIV in prison — evidence of risk. BMJ, 307: 622–623Google Scholar
  13. 13.
    Bird, A.G., Gore, S.M., Joliffe, D.W., Burns, S.M. (1992): Anonymous HIV surveillance in Saughton Prison, Edinburgh. AIDS, 6: 725–733PubMedCrossRefGoogle Scholar
  14. 14.
    Bird, A.G., Gore, S.M., Burns, S.M., Duggie, J.G. (1993): Study of infection with HIV and related risk factors in young offender’ institution. BMJ 1993, 307: 228–230Google Scholar
  15. 15.
    Müller, R.; Stark, K., Guggenmoos-Holzmann, I., Wirth, D., Bienzle, U. (1995): Imprisonment: a risk factor for HIV infection counteracting education and prevention programmes for intravenous drug users. AIDS, 9: 183–190PubMedGoogle Scholar
  16. 16.
    Crofts, N., Stewart, T., Hearne, P., Yi Ping, X., Breschkin, A.M., Locarnini, S.A(1995): BMJ, 310: 285–288PubMedCrossRefGoogle Scholar
  17. 17.
    Taylor, A., Goldberg, D., Emslie, J., Wrench, J., Gruer, L., Cameron, S. et al. (1995): Outbreak of HIV infection in a Scottish prison. BMJ, 310: 289–292PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Caren Weilandt
    • 1
  • Michel Rotily
    • 2
  1. 1.WIAD: Scientific Institute of the German Medical AssociationBonnGermany
  2. 2.ORS: Observatoire Régional de la SantéProvence, Alpes, Côte d’Azur, MarseilleFrance

Personalised recommendations